MarketsSingle-source
2.1
Double Bond Pharma reports Q2 2026 operating loss of 0.6 million SEK
Dagens IndustriLO·SE·1 day ago
Zenergy reported improved financial performance for Q2 2026, characterized by increased revenue and a reduction in operating losses. The report indicates a positive trend in operational efficiency, though specific margin data and forward-looking guidance remain undisclosed.